Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Almost 50% percent of population suffers from tooth sensitivity

Almost 50% percent of the population suffers from tooth sensitivity to cold, sweet and hot foods and liquids, according to a nationwide survey of 1,056 adults age 18—65+. Almost half of respondents had tried sensitivity toothpastes, but only about one-third of those found their experience to be positive, noted Larry Fishman, president of Majestic Drug Co., Inc.

2 Aug 2013

FDA promise to "reboot" antibiotic development rules to combat rise in resistance falls short

The rise of antibiotic resistance among hospital-acquired infections is greater than the Centers for Disease Control and Prevention found in its 2008 analysis, according to an ahead-of-print article in the journal, Antimicrobial Agents and Chemotherapy.

2 Aug 2013

ATS releases clinical practice guidelines on management of childhood ILD in infants

The American Thoracic Society has released new clinical practice guidelines on the classification, evaluation and management of childhood interstitial lung disease in infants.

1 Aug 2013

Phase III trial shows afatinib offers clinical benefit to patients with EGFR mutation positive NSCLC

Afatinib has a novel mode of action and data has shown that it offers a clinical benefit to patients with a specific type of lung cancer, which we are further investigating in the extensive LUX-Lung clinical trial programme.

1 Aug 2013

Prevention against EEE and West Nile virus is within everyone's control

Every year reported cases of Eastern Equine Encephalitis and the West Nile virus surface in communities around the country, raising concerns and questions about mosquito borne-illnesses. Despite reports that children and the elderly are at greatest risk, anyone can be stricken by these viruses. But prevention is within everyone's control.

1 Aug 2013

Chemists develop new method for parallel protein analysis

Chemists at Johannes Gutenberg University Mainz (JGU) have developed a new method for parallel protein analysis that is, in principle, capable of identifying hundreds or even thousands of different proteins. It could be used to detect the presence of viruses and identify their type in tiny samples. At the same time, it is very cost-effective and quick.

31 Jul 2013

Nektar completes enrollment in NKTR-102 BEACON trial in patients with metastatic breast cancer

Nektar Therapeutics (NASDAQ: NKTR) today announced that enrollment is complete in the pivotal clinical study of etirinotecan pegol (NKTR-102) in patients with metastatic breast cancer.

31 Jul 2013

Antibiotic prescribing rates can be reduced using internet-based training for clinicians

Antibiotic prescribing rates for acute respiratory tract infections could be significantly lowered using internet-based training for clinicians, new research has shown.

31 Jul 2013

WHO aims to increase global rate of breastfeeding for six months to 50% by 2025

Only 37 countries, or 19% of those reporting, have passed laws reflecting all the recommendations of the International Code of Marketing of Breast-milk Substitutes, according to a new World Health Organization (WHO) report published during World Breastfeeding Week. The week is celebrated in more than 170 countries from 1 to 7 August.

30 Jul 2013

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Genotype 1 is, worldwide, the most prevalent genotype of the hepatitis C virus. It accounts for around seventy percent of all hepatitis C infections.

30 Jul 2013

Saudi and UK scientists provide detailed picture of MERS coronavirus

Saudi and UK scientists provide the most detailed picture yet of the clinical and laboratory characteristics of Middle East Respiratory Syndrome (MERS) coronavirus, revealing a wide range of clinical symptoms and an extremely high death rate among patients with co-existing medical conditions.

29 Jul 2013

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy

26 Jul 2013

Weekend reading: The mystery of some innovations that are slow to be accepted; myths about the obesity crisis

Why do some innovations spread so swiftly and others so slowly? Consider the very different trajectories of surgical anesthesia and antiseptics. ... On October 16, 1846, at Massachusetts General Hospital, Morton administered his gas through an inhaler in the mouth of a young man undergoing the excision of a tumor in his jaw. ... By February, anesthesia had been used in almost all the capitals of Europe, and by June in most regions of the world.

26 Jul 2013

New species of adenovirus can spread from monkey to human, say researchers

Adenoviruses commonly infect humans, causing colds, flu-like symptoms and sometimes even death, but now UC San Francisco researchers have discovered that a new species of adenovirus can spread from primate to primate, and potentially from monkey to human.

26 Jul 2013

FDA allows marketing of Xpert MTB/RIF Assay for treatment of TB

The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.

26 Jul 2013

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the first lots of Fluzone (Influenza Virus Vaccine) for the 2013-2014 season have been released by the U.S. Food and Drug Administration for U.S. distribution and were shipped July 24.

25 Jul 2013

Discovery of pressure-driven infection mechanism opens door to new treatments for viral infections

The virus that causes those painful lip blisters known as cold sores has an internal pressure eight times higher than a car tire, and uses it to literally blast its infectious DNA into human cells, scientists are reporting in a new study.

25 Jul 2013

Study reveals African bats may play a role in evolution of MERS-CoV predecessor viruses

The MERS-coronavirus is regarded as a dangerous novel pathogen: Almost 50 people have died from infection with the virus since it was first discovered in 2012. To date all cases are connected with the Arabian peninsula. Scientists from the University Bonn (Germany) and South Africa have now detected a virus in the faeces of a South African bat that is genetically more closely related to MERS-CoV than any other known virus.

25 Jul 2013

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Inovio Pharmaceuticals, Inc. announced today that in a preclinical study with two animal models, Inovio's hTERT (human telomerase reverse transcriptase) DNA cancer vaccine administered with Inovio's CELLECTRA adaptive electroporation delivery technology generated robust and broad immune responses, broke the immune system's tolerance to its self-antigens, induced T-cells with a tumor-killing function, and increased the rate of survival.

24 Jul 2013

Diet soda: No better than regular soda

You may be saving calories by drinking diet soda, but when it comes to enamel erosion of your teeth, it's no better than regular soda.

24 Jul 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Almost 50% percent of population suffers from tooth sensitivity

FDA promise to "reboot" antibiotic development rules to combat rise in resistance falls short

ATS releases clinical practice guidelines on management of childhood ILD in infants

Phase III trial shows afatinib offers clinical benefit to patients with EGFR mutation positive NSCLC

Prevention against EEE and West Nile virus is within everyone's control

Chemists develop new method for parallel protein analysis

Nektar completes enrollment in NKTR-102 BEACON trial in patients with metastatic breast cancer

Antibiotic prescribing rates can be reduced using internet-based training for clinicians

WHO aims to increase global rate of breastfeeding for six months to 50% by 2025

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Saudi and UK scientists provide detailed picture of MERS coronavirus

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Weekend reading: The mystery of some innovations that are slow to be accepted; myths about the obesity crisis

New species of adenovirus can spread from monkey to human, say researchers

FDA allows marketing of Xpert MTB/RIF Assay for treatment of TB

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Discovery of pressure-driven infection mechanism opens door to new treatments for viral infections

Study reveals African bats may play a role in evolution of MERS-CoV predecessor viruses

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Diet soda: No better than regular soda

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in